Safety of transarterial chemoembolization as bridging therapy in HCC patients with hyperbilirubinemia on the waiting list for liver transplantation: A centre experience

Hepato-Gastroenterology

Volumn 60, Issue 128, 2013, Pages 2076-2079

  Thorat, Ashok ^a   Lee, Chen Fang ^a   Wu, Tsung Han ^a   Chan, Kun Ming ^a   Chou, Hong Shiue ^a   Lee, Wei Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Hepatocellular carcinoma; Hyperbilirubinemia; Transarterial chemoembolization

Indexed keywords

BILIRUBIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; KIDNEY DYSFUNCTION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; METABOLIC DISORDER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT SAFETY; PORTAL VEIN THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR GROWTH;

ADULT; BILIRUBIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERBILIRUBINEMIA; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84893640148     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12434     Document Type: Article

References (21)

1. Sharif MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD: Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3:353-367.
2. Toshikuni N, Takuma Y, Morimoto Y, Shimomura H, Yamamoto H: Transarterial embolization for ruptured hepatocellular carcinoma: survival predictors. Hepato-gastroenterology 2011; 106(58):565-569.
3. Fujiki M, Aucejo F, Kim R: General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option? Liver Inter 2011; 31(8):1081-1089.
4. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. (Pubitemid 43112690)
5. Yau FY, Kerlan Rk Jr, Hirose R, et al.: Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48:819-827.
6. Chapman WC, Majella Doyle MB, Stuart JE, et al.: outcome of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008; 248:617-625.
7. Mondazzi L, Bottelli R, Brambilla G, et al.: Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19:1115-1123.
8. Brown DB, Pilgram TK, Darcy MD, et al.: Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005; 16:1661-1666. (Pubitemid 44431163)
9. Biselli M, Andreone P, Gramenzi A, et al.: Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Heapatol 2005; 3:918-925. (Pubitemid 41219296)
10. Biolato M, Marrone G, Racco S, et al.: Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Eur Rev Med Pharmacol Sci 2010; 14(4):356-362.
11. Kulik LM, Carr BI, Mulcahy MF, et al.: Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008; 47:71-81. (Pubitemid 351171043)
12. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37:429-442. (Pubitemid 36152543)
13. Hayashi PH, Ludkowski M, Forman LM, et al.: Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 2004; 4:782-787. (Pubitemid 38637578)
14. Maddala YK, Stadheim L, Andrews JC et al.: Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transpl 2004; 10:449-455. (Pubitemid 38380323)
15. Grazeadie IW, Sandmueller H, Waldenberger P, et al.: Chemoembolization followed by liver transplantation for hepatocellular impedes tumour progression while on the waiting list and leads to excellent outcome. Liver Transplant 2003; 9:557-563. (Pubitemid 36701690)
16. Roayaie S, Frischer JS, Emre SH, et al.: Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235:533-539. (Pubitemid 34258353)
17. Millionig G, Graziadei IW, Freund MC, et al.: Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver transplant 2007; 13:272-279. (Pubitemid 46351654)
18. De Luna W, Sze DY, Ahmed A, et al.: Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and bridge toward liver transplantation, Am J transplant 2009; 9:1158-1168.
19. Pérez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y: Is transarterial chemoembolization is necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005; 190:383-387. (Pubitemid 41139290)
20. Decatens T, Roudot-Thoraval F, Bresson-Hadni S: Impact of pretransplantation TACE on survival and recurrence after liver transplantation for HCC. Liver Transplantation 2005; 11:767-775. (Pubitemid 40975578)
21. Majno PE, Adam R, Bismuth H, et al.: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-701.